Sci-Engi-Medco Solutions, Inc.

Saint Charles, MO

UEI
QFW6NVACLNU3
CAGE
69FE8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Asian-Pacific American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
573 Lexington Landing Pl, St Charles, MO 63303, USA
Website
semcostl.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Theranostics of reduction of cardiotoxicity using targeted apoptosis activation technology R43CA214223 National Cancer Institute (NIH) $274,452
Dual targeted human beta defensin for improving chemotherapy R43CA183353 National Institutes of Health $264,958

Quick answers

Is Sci-Engi-Medco Solutions, Inc. registered in SAM.gov?

Yes. Sci-Engi-Medco Solutions, Inc.'s SAM.gov registration is active through December 23, 2026.

What is Sci-Engi-Medco Solutions, Inc.'s most recent federal award?

Sci-Engi-Medco Solutions, Inc.'s most recent federal grant award is Theranostics of reduction of cardiotoxicity using targeted apoptosis activation technology (R43CA214223), from National Cancer Institute (NIH), on September 6, 2017.

On GovTribe

See Sci-Engi-Medco Solutions, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login